Abstract
The evidence suggests that paracetamol/ibuprofen combinations as an intravenous formulation can be offered as an alternative to other analgesics for the short-term management of mild to moderate acute pain. The aim of this study was to evaluate the economic impact of the introduction of this combination analgesic from the National Health Service (NHS) perspective in Italy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
